Related Experiment Video

Updated: Sep 7, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.7K

PGC-1α participates in tumor chemoresistance by regulating glucose metabolism and mitochondrial function

Yanqing Li1, Hu Hei1, Songtao Zhang1

  • 1Department of Thyroid and Neck, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450003, China.

Molecular and Cellular Biochemistry
|June 17, 2022
PubMed

Insights

Chemotherapy resistance, a major challenge in cancer treatment, involves complex mechanisms. This study explores the role of PGC-1α in cancer cell metabolism and mitochondrial function, clarifying its controversial impact on drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Chemotherapy resistance significantly hinders cancer treatment efficacy.
  • Cancer cells exhibit complex and diverse drug resistance mechanisms.
  • Altered glucose metabolism and mitochondrial function are increasingly recognized in cancer resistance.

Purpose of the Study:

  • To investigate the role of PGC-1α in regulating glucose metabolism and mitochondrial function in cancer cells.
  • To provide a comprehensive overview of PGC-1α's function in chemotherapy resistance.
  • To address the controversial role of PGC-1α in cancer drug resistance.

Main Methods:

  • Literature review focusing on PGC-1α, glucose metabolism, and mitochondrial function.
  • Analysis of studies investigating PGC-1α's impact on cancer cell metabolic plasticity.
  • Synthesis of current research on PGC-1α's involvement in chemotherapy resistance.

Main Results:

  • PGC-1α is a key regulator of mitochondrial biogenesis and function.
  • Cancer cells display metabolic plasticity, adapting mitochondrial function to resist chemotherapy.
  • The precise role of PGC-1α in chemotherapy resistance remains debated, with evidence suggesting both pro- and anti-resistance functions.

Conclusions:

  • Understanding PGC-1α's multifaceted role in metabolic adaptation is crucial for developing strategies to overcome chemotherapy resistance.
  • Targeting PGC-1α or related metabolic pathways may offer novel therapeutic approaches.
  • Further research is needed to fully elucidate PGC-1α's complex contribution to cancer drug resistance.
Keywords:
CancerChemoresistanceMetabolismMitochondrionPGC-1α

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.8K
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.6K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K